July 25, 2024 at 12:56 pm

AI Drug Discovery Predicative Oncology (POAI) Rises 70% on Successful Ovarian Cancer Study, Enters Biomarker Discovery Market

Today the PRISM NextGen Tech and AI Index leader Predicative Oncology (POAI) announced it will enter the $51.5M biomarker discovery market. This decision to expand their AI/ML driven drug discovery platform to pursue discovery of novel biomarkers that can be used to predict patient outcomes and drug response in oncology, comes on the heels of… [Read More]
July 25, 2024 at 12:47 pm

ServiceNow’s Cloud RISES and So Does its stock.

ServiceNow (NYSE:NOW) saw a significant surge in their share prices following an updated forecast for their annual subscription revenue. The Q2 financial results exceeded market expectations, garnishing further investor confidence. Additionally, the company has announced organizational changes with Chris Bedi stepping in as the interim Chief Product Officer following the departure of COO CJ Desai…. [Read More]
July 25, 2024 at 9:08 am

Stocks making the biggest moves premarket: American Airlines, Honeywell, RTX, Ford and more

Following the release of their third-quarter profit guidance, American Airlines’ stocks decreased by 6%. They predict unit revenue will fall by up to 4.5% as the industry grapples with oversupply and low fares. Despite better-than-expected quarterly numbers, Honeywell’s shares fell almost 5% after the company’s guidance failed to meet analyst expectations. Southwest Airlines’ shares dipped… [Read More]
July 24, 2024 at 3:42 pm

Vigil Neuroscience Reports Interim Data on Oral Therapy for Alzheimer’s

Vigil Neuroscience (NASDAQ: VIGL) announced interim data from its ongoing Phase 1 clinical trial of VG-3927, a once-daily oral therapy for Alzheimer’s disease (AD). The data from healthy volunteers supports continued development, showcasing the therapy’s safety, tolerability, and efficacy. VIGL shares traded up 11% midday on the news. Key Highlights: VG-3927 exhibited a favorable safety… [Read More]
July 24, 2024 at 12:57 pm

Mag 7 Earnings Start Off as A Drag as Alphabet (GOOG) and Telsa (TSLA) Underwhelm

Disappointing earnings takeaways came from today’s Mag 7 reports from Alphabet (GOOG) and Tesla (TSLA) as concerns related to concentration, 2H earnings growth slowdown and elevated AI capex vs monetization have had investors waiting to see what the industry leaders would report. Alphabet reported mostly better Q2 results citing momentum in core Search and Cloud… [Read More]
July 24, 2024 at 12:37 pm

Got Oats? Oatly (OTLY) Reports Q2 Earnings Beats Estimates, Raises Guidance

The PRISM Consumer Products Index company Oatly Group AB (OTLY) reported its Q2 financials beating estimates on EPS ($0.05) vs FactSet (0.07), revenues $202.2M vs FactSet $201.3M and adjusted EBITDA ($11.0M) vs FactSet ($15.8M). FY 2024 guidance was increased on constant currency revenue growth +6%-10% vs prior guidance +5%-10% and but trimmed guidance on adjusted… [Read More]
July 24, 2024 at 12:28 pm

Stocks Slide on AI Concerns: Markets Wrap

Alphabet’s shares slump as investors wait for AI to pay off Tesla sinks as carmaker tethers future to delayed robotaxis Stocks tumbled after a disappointing start to the megacap earnings season, sparking speculation that the artificial-intelligence frenzy driving the bull market still needs to deliver tangible returns. A selloff in major technology companies pushed the… [Read More]
July 24, 2024 at 8:55 am

Stocks making the biggest moves premarket: Alphabet, Tesla, Texas Instruments, Meta Platforms and more

Here’s a sneak peek at some firms making waves in premarket trading: Alphabet – The parent company of Google experienced a near 4% decline in stocks before market opening as its YouTube advertising revenue didn’t meet Q2 expectations, despite outperforming top and bottom-line estimates. Tesla – The EV giant’s stocks plunged around 9% following weaker-than-anticipated… [Read More]
July 23, 2024 at 2:10 pm

Eyenovia and Senju Pharmaceutical Ink Collaboration to Combat Chronic Dry Eye Disease; Shares Rise 21%

Eyenovia, Inc. (NASDAQ: EYEN) and Senju Pharmaceutical Co., Ltd. (Senju) have announced a collaboration to develop a formulation of Senju’s SJP-0035 for use with Eyenovia’s Optejet® dispensing technology. This partnership aims to create a novel treatment for chronic dry eye disease, following consultation with the U.S. Food and Drug Administration (FDA). EYEN shares traded 21%… [Read More]